Yahoo Finance

Global $300+ Million PFO Amplatzer Markets to 2027

Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Global PFO Amplatzer Market, By Type, Application & By Region - Forecast and Analysis 2022-2027" report has been added to ResearchAndMarkets.com's ...
Yahoo Finance

PFO Amplatzer Market is Anticipated to Attain a Value of USD 337.76 Million by Growing at a CAGR of 11.8% During 2022-2028; Rising Congenital Heart Illness to Elevate Market Growth

Westford USA, Feb. 16, 2023 (GLOBE NEWSWIRE) -- North America to lead the PFO amplatzer market in 2021 and is estimated to keep dominating the market growth by gathering the highest market share ...
elEconomista

St. Jude Medical Announces FDA Approval and U.S. Launch of the First and Only Medical Device Indicated to Reduce the Risk of Recurrent Ischemic Stroke in Patients with a PFO

With the approval of the AMPLATZER PFO Occluder, patients in the U.S. with a PFO who have suffered an ischemic stroke – a stroke resulting from blockages in the blood supply to the brain – will now ...
TCTMD

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

(UPDATED) Patent foramen ovale (PFO) closure using the Amplatzer device for the prevention of recurrent stroke should be approved as an option for patients with cryptogenic stroke, the majority of a ...
TCTMD

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Ending a decades-long wait, the US Food and Drug Administration (FDA) today approved the Amplatzer PFO Occluder device (St. Jude Medical) for recurrent stroke prevention in patients with a patent ...
PharmiWeb

FDA APPROVES ABBOTT'S AMPLATZER™ TALISMAN™ SYSTEM FOR PFO CLOSURE IN PEOPLE AT RISK OF RECURRENT STROKE

- Talisman system builds on the minimally invasive Amplatzer PFO Occluder, the world's leading patent foramen ovale (PFO) closure device that has been used to treat more than 180,000 patients ...
Business Wire

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

PFO closure with the AMPLATZER PFO Occluder is potentially a novel prevention strategy that may be superior to medications alone,” said Dr. John D. Carroll, director of the Cardiac and Vascular Center ...